System and method for utilizing exhaled breath for monitoring inflammatory states
View Patent ↗A system for monitoring an exhaled breath of a subject is described. A breath collector can be configured to receive exhaled breath from a subject. One or more sensors can be configured to output a concentration of a first gas compound in the received exhaled breath, and to output a concentration of a second gas compound in the received exhaled breath. The second gas compound is used to normalize the concentration of the first gas based on different physiological states of the subject. A processor operably coupled to the one or more sensors is configured to calculate a ratio of the first gas compound to the second gas compound based on the determined concentrations, and to determine a normalized concentration of the first gas compound. This ratio may be monitored to evaluate an inflammatory state of the subject.
1. A method comprising:
collecting a sample of inhaled breath from a subject and measuring the concentration of carbon monoxide in the inhaled breath;
collecting a sample of exhaled breath from the subject;
measuring the concentration of carbon monoxide in the collected sample of inhaled breath;
measuring the concentration of carbon monoxide in the collected sample of exhaled breath;
determining a background-subtracted concentration of carbon monoxide by subtracting the measured concentration of carbon monoxide in the collected sample of inhaled breath from the measured concentration of carbon monoxide in the collected sample of exhaled breath;
measuring the concentration of carbon dioxide in the collected exhaled sample;
calculating a ratio of the concentration of the background-subtracted concentration of carbon monoxide to the concentration of carbon dioxide to determine a normalized concentration of carbon monoxide; and
diagnosing a disease state based on the normalized concentration of carbon monoxide.
2. The method of claim 1 , further comprising:
comparing the normalized concentration of carbon monoxide to a predetermined set of values of concentration levels for the normalized concentration of carbon monoxide; and
when the normalized concentration of carbon monoxide exceeds a particular predetermined value, diagnosing the subject with a disease state.
3. The method of claim 2 , further comprising:
administering a treatment regimen to the subject based on the disease state;
determining a follow-up normalized concentration of carbon monoxide in another collected sample of inhaled and exhaled breath from the subject, the other sample collected after the treatment regimen has commenced; and
evaluating an effectiveness of the treatment regimen based on the determined follow-up normalized concentration of carbon monoxide.
4. The method of claim 1 , wherein the disease state is an infection that is one of a parasite infection, a viral infection, a bacterial infection, or fungal infection.
5. The method of claim 4 , wherein the infection comprises sepsis.
6. The method of claim 1 , wherein the disease state comprises an autoimmune disease.
7. A method comprising:
collecting a set of samples of inhaled breath and exhaled breath from a subject over a period of time;
measuring the concentration of carbon monoxide in the samples of inhaled breath and exhaled breath;
determining a background-subtracted concentration of carbon monoxide in the set of samples by subtracting the measured concentration of carbon monoxide in the collected samples of inhaled breath from the measured concentration of carbon monoxide in the collected samples of exhaled breath;
normalizing the background-subtracted concentrations of carbon monoxide to a measured concentration of carbon dioxide to generate normalized concentrations of carbon monoxide;
determining a change in the normalized concentration of carbon monoxide over the period of time; and
evaluating an inflammatory state of the subject based on the determined change in the normalized concentration of carbon monoxide.
8. The method of claim 7 , wherein the inflammatory state comprises an infection comprising one of a viral infection, a parasite infection, a bacterial infection, and a fungal infection.
9. The method of claim 7 , wherein the inflammatory state comprises an autoimmune disease.
10. The method of claim 7 , wherein the inflammatory state comprises trauma.
11. A device, comprising:
a breath collector configured to receive inhaled and exhaled breath from a subject;
one or more sensors configured to output a concentration of carbon monoxide in the received inhaled and exhaled breaths and to output a concentration of carbon dioxide in the received exhaled breath; and
a processor operably coupled to the one or more sensors and further configured to calculate a background-subtracted concentration of carbon monoxide by subtracting the measured concentration of carbon monoxide in the received inhaled breath from the measured concentration of carbon monoxide in the received exhaled breath and further calculate a ratio of the background-subtracted concentration of carbon monoxide to the concentration of carbon dioxide.
12. The device of claim 11 , wherein the processor is further configured to output a diagnosis of a disease state based on the ratio.
13. The device of claim 12 , wherein the disease state is one of a viral infection, bacterial infection, parasite infection, and fungal infection.
14. The device of claim 11 , wherein the processor is further configured to compare the ratio to a set of predetermined values representative of the presence or absence of a disease state, wherein the presence or absence of the disease state is output when the ratio exceeds a corresponding predetermined value.
15. The device of claim 11 , wherein the sensor outputs real-time or near real-time concentrations of carbon monoxide and carbon dioxide.